Kerstin Rhiem - Concepedia

Author

Kerstin Rhiem

Also Known As

C. Singer, Christian F Singer, Jan Hauke, Johanna Rantala, K Rhiem, K. Rhiem, Karin Kast, Kerstin Rhiem, Loris Bernard, Nazneen Rahman

123

Publications

Citations

H-Index

Concepts

All Affiliations

University Hospital Cologne Leipzig University University of Cologne Heinrich Heine University Düsseldorf Technische Universität Dresden

About

Kerstin Rhiem is an author at University Hospital Cologne specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	678
2	Public Health	5	5	298
3	Engineering	1	1	51
4	Health Sciences	1	1	134
5	Biostatistics	1	1	148

Kerstin Rhiem

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Eric Hahnen, Bianca Lederer, Jan Hauke, JAMA Oncology	2017	385
Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Monika Graeser, Christoph Engel, Kerstin Rhiem, Journal of Clinical Oncology	2009	309
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, European Urology	2019	231
Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Journal of Medical Genetics	2016	217
Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer Jan Hauke, Judit Horváth, Eva Groß, Cancer Medicine	2018	161
Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification Michael T. Parsons, Emma Tudini, Hongyan Li, Human Mutation GeneticsGenetic EpidemiologyPathologyMultifactorial Likelihood AnalysisDisease Gene Identification	2019	148
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer Ulrich Bick, Christoph Engel, B. Krug, Breast Cancer Research and Treatment Breast OncologyRadiologyMedical ImagingGerman ConsortiumCancer Screening	2019	134
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer Nana Weber‐Lassalle, Jan Hauke, Juliane Ramser, Breast Cancer Research	2018	127
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study Kerstin Rhiem, Christoph Engel, Monika Graeser, Breast Cancer Research	2012	121

Page 1